SCHEMBL6584239

SCHEMBL6584239

O=C(Cl)c1ccccc1-c1ccccc1C(F)(F)F

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.49
GAA P10253 1/20 0.49
ALDH1A1 P00352 2/20 0.47
ALOX15 P16050 1/20 0.47
HPGD P15428 1/20 0.46
PARP1 P09874 1/20 0.43
AKR1C3 P42330 1/20 0.42
AKR1C2 P52895 1/20 0.42
PPIA P62937 1/20 0.42
KMO O15229 2/20 0.42
PTPRC P08575 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CTNNB1 P35222 1/20 0.41
WNT3A P56704 1/20 0.41
THRA P10827 1/20 0.40
THRB P10828 1/20 0.40
CNR2 P34972 1/20 0.40
HSD11B1 P28845 1/20 0.40
NFKB1 P19838 1/20 0.40
MAPK14 Q16539 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24201 0.84 LMNA (0.60) LMNAGAAALDH1A1ALOX15PPIA
SCHEMBL344491 0.83 ALDH1A1 (0.56) LMNAGAAALDH1A1ALOX15HPGD
SCHEMBL11009342 0.83 ALDH1A1 (0.42) LMNAGAAALDH1A1ALOX15HPGD
SCHEMBL29688494 0.82 ALDH1A1 (0.58) LMNAGAAALDH1A1ALOX15HPGD
SCHEMBL993303 0.82 ALDH1A1 (0.58) LMNAGAAALDH1A1ALOX15HPGD
SCHEMBL5143960 0.81 PARP1 (0.56) LMNAGAAALDH1A1HPGDPARP1
SCHEMBL30608075 0.81 PARP1 (0.56) LMNAGAAALDH1A1HPGDPARP1
SCHEMBL10907542 0.77 LMNA (0.41) LMNAGAAALDH1A1HPGDPARP1
SCHEMBL197671 0.77 HSD11B1 (0.56) ALDH1A1ALOX15HPGDHSD11B1
Benzoyl Chloride SCHEMBL8103514 0.76 LMNA (0.51) LMNAGAAALDH1A1ALOX15CTNNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1379515-A1 LIPID LOWERING BIPHENYLCARBOXAMIDES JANSSEN PHARMACEUTICA N.V. (BE) 2004-01-14 EP disclosed
EP-1326835-A1 BENZAMIDE COMPOUNDS AS APO B SECRETION INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-07-16 EP disclosed
EP-1317431-A2 POLYARYLCARBOXAMIDES USEFUL AS LIPID LOWERING AGENTS JANSSEN PHARMACEUTICA N.V. (BE) 2003-06-11 EP disclosed
WO-2002081460-A1 LIPID LOWERING BIPHENYLCARBOXAMIDES JANSSEN PHARMACEUTICA N.V. (BE) 2002-10-17 WO disclosed
WO-2002028835-A1 BENZAMIDE COMPOUNDS AS APO B SECRETION INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-04-11 WO disclosed
WO-2002020501-A2 POLYARYLCARBOXAMIDES USEFUL AS LIPID LOWERING AGENTS JANSSEN PHARMACEUTICA N.V. (BE) 2002-03-14 WO disclosed
EP-0887345-A1 4'-trifluoromethylbiphenyl-2-carboxylic acid-[2-(2-acetylaminoethyl)-1,2,3,4-tetrahydroisoquinolin-6-yl]amide hydrochloride as apo B-secretion/MTP inhibitors PFIZER INC. (US) 1998-12-30 EP disclosed